How I treat venous thrombosis in children

Blood

Volumn 107, Issue 1, 2006, Pages 21-29

  Manco Johnson, Marilyn J ^a,b  

^a Mountain States Regional Hemophilia and Thrombosis Center   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; VALSALVA MANEUVER;

EID: 30144438106     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2004-11-4211     Document Type: Review

References (71)

1. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr. 1993;123:337-346.
2. David M, Manco-Johnson M, Andrew M. Diagnosis and treatment of venous thromboembolism in children and adolescents. Thromb Haemost. 1995;74:791-792.
3. Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest. 1995;108 (suppl 4): 506S-522S.
4. Manco-Johnson MJ. Diagnosis and management of thromboses in the perinatal period. Semin Perinatol. 1990;14:393-402.
5. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163-F167.
6. Chevalier RL. What treatment do you advise for bilateral or unilateral renal thrombosis in the newborn, with or without thrombosis of the inferior vena cava? Pediatr Nephrol. 1991;5:679.
7. Seibert JJ, Northington FJ, Miers JF, Taylor BJ. Aortic thrombosis after umbilical artery catheterization in neonates: prevalence of complications on long-term follow-up. AJR. 1991;156:567-569.
8. Ricci MA, Lloyd DA. Renal venous thrombosis in infants and children. Arch Surg. 1990;125:1195-1199.
9. Barron TF, Gusnard DA, Zimmerman RA, Clancy RR. Cerebral venous thrombosis in neonates and children. Pediatr Neurol. 1992;8:112-116.
10. Ross P Jr, Ehrenkranz R, Kleinman CS, Seashore JH. Thrombus associated with central venous catheters in infants and children. J Pediatr Surg. 1989;24:253-256.
11. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian registry of venous thromboembolic complications. J Pediatr. 1998;133:770-776.
12. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000;47:763-766.
13. van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr. 2001;139:676-681.
14. Bounameaux H, Perrier A, Wells PS. Clinical and laboratory diagnosis of deep vein thrombosis: new cost-effective strategies. Semin Vasc Med. 2001;1:39-42.
15. Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr. 2000;136:446-453.
16. Joffe HV, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation. 2002;106:1874-1880.
17. Sharafuddin MJ, Sun S, Hoballah JJ. Endovascular management of venous thrombotic diseases of the upper torso and extremities. J Vasc Interv Radiol. 2002;13:975-990.
18. Male C, Chait P, Ginsberg JS, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Thromb Haemost. 2002;87:593-598.
19. Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. New Engl J Med. 2003;349:1247-1256.
20. Kearon C. Diagnosis of pulmonary embolism. CMAJ. 2003;168:183-194.
21. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics. 1995;96:291-294.
22. Dix D, Andrew M, Marzinotto V, et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr. 2000;136:439-445.
23. Wang M, Hays T, Balasa V, et al. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. 2003;25:379-386.
24. Manco-Johnson MJ, Knapp-Clevenger R, Miller B, Hays T. Post-thrombotic syndrome (PTS) in children: validation of a new pediatric outcome instrument and results in a comprehensive cohort of children with extremity deep vein thrombosis (DVT) [abstract]. Blood. 2003;102:553a. Abstract 2032.
25. Häusler M, Hübner D, Delhaas T, Mühler EG. Long term complications of inferior vena cava thrombosis. Arch Dis Child. 2001;85:228-233.
26. Kuhle S, Koloshuk B, Marzinotto V, et al. A crosssectional study evaluating post-thrombotic syndrome in children. Thromb Res. 2003;111:227-233.
27. Franzeck UK, Schalch I, Bollinger A. On the relationsip between changes in the deep veins evaluated by duplex sonography and the postthrombotic syndrome 12 years after deep vein thrombosis. Thromb Haemost. 1997;77:1109-1112.
28. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness D Jr. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg. 1993;18:596-608.
29. Revel-Vilk S, Sharathkumar A, Massicotte P, et al. Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thromb Haemost. 2004;2:42-46.
30. Manco-Johnson M, Graham D, Valentino L, Knapp-Clevenger R. Low molecular weight heparin dose requirements are age-related through childhood [abstract 1622]. Pediatr Res. 2003;53:284.
31. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:645S-687S.
32. Hirsh J, Raschke R. Heparin and low-molecularweight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:188S-203S.
33. Baglin R, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362:523-526.
34. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and Ddimer levels as predictors of poor outcomes of thrombosis in children. New Engl J Med. 2004;351:1081-1088.
35. Nowak-Göttl U, Junker R, Kreuz W, et al, for the Childhood Thrombophilia Study Group. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001;97:858-862.
36. Caprini JA, Glase CJ, Anderson CB, Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004;109(suppl I):I4-I8.
37. Viles-Gonzalez JF, Fuster V, Badimon JJ. Thrombin/inflammation paradigms: a closer look at arterial and venous thrombosis. Am Heart J. 2005;149:S19-S31.
38. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457-462.
39. Eichinger S, Minar E, Bialonczyk C, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA. 2003;290:1071-1074.
40. Meissner MH, Zierler BK, Bergelin RO, Chandler WL, Strandness DE Jr. Coagulation, fibrinolysis, and recanalization after acute deep vein thrombosis. J Vasc Surg. 2002;35:278-285.
41. Krieger E, van Der Loo B, Amann-Vesti BR, Rousson V, Koppensteiner R. C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis. J Vasc Surg. 2004;40:644-649.
42. McDonald MM, Jacobson LJ, Hay WW Jr, Hathaway WE. Heparin clearance in the newborn. Pediatr Res. 1981;15:1015-1018.
43. McDonald MM, Hathaway WE. Anticoagulant therapy by continuous heparinization in newborn and older infants. J Pediatr. 1982;101:451-457.
44. McDonald MM, Hathaway WE. Neonatal hemorrhage and thrombosis. Semin Perinatol. 1983;7:213-225.
45. Burk CD, Miller L, Handler SD, Cohen AR. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics. 1992;89:691-695.
46. Josephson C, Nuss R, Jacobson L, et al. The varicella-autoantibody syndrome. Pediatr Res. 2001;50:345-352.
47. Nuss R, Hays T, Chudgar U, Manco-Johnson M. Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli. J Pediatr Hematol Oncol. 1997;19:202-207.
48. Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AW. Low molecular weight heparin: a critical analysis of clinical trials. Pharmacol Rev. 1994;46:89-109.
49. Turpie AGG. State of the art: a journey through the world of antithrombotic therapy. Semin Thromb Hemost. 2002;28:3-11.
50. Punzalan RC, Hillery CA, Montgomery RR, Scott CA, Gill JC. Low-molecular weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol. 2000;22:137-142.
51. Massicotte P, Adams M, Marzinotto V, Brooker L, Andrew M. Low molecular weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr. 1996;128:313-318.
52. Nohe N, Flemmer A, Rümler R, Praun M, Auberger K. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur J Pediatr. 1999;158(suppl 3):S134-S139.
53. Manco-Johnson M, Knapp-Clevenger R. Successful antithrombotic therapy employing intravenous bolus low molecular weight heparin in an extremely premature infant [abstract 1621]. Pediatr Res. 2003;53:284.
54. Bush RL, Lin PH, Bates JT, Mureebe L, Zhou W, Lumsden AB. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg. 2004;40:965-970.
55. Augustinos P, Ouriel K. Invasive approaches to treatment of venous thromboembolism. Circulation. 2004;110(suppl I):I27-I34.
56. Lamont JP, Pearl GJ, Patetsios P, et al. Prospective evaluation of endoluminal venous stents in the treatment of the May-Thurner syndrome. Ann Vasc Surg. 2002;16:61-64.
57. Ing FF, Fagan TE, Grifka RG, et al. Reconstruction of stenotic or occluded iliofemoral veins and inferior vena cava using intravascular stents: reestablishing access for future cardiac catheterization and cardiac surgery. J Am Coll Cardiol. 2001;37:251-257.
58. Hartman KR, Manco-Johnson M, Rawlings JS, Bower DJ, Marlar RA. Homozygous protein C deficiency: early treatment with warfarin. Am J Pediatr Hematol Oncol. 1989;11:395-401.
59. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood. 1999;94:3007-3014.
60. Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant factor VII to reverse warfarininduced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg. 2003;98:737-740.
61. Sorensen B, Johansen P, Nielsen GL, Sorensen JC, Ingerslev J. Reversal of the international normalized ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis. 2003;14:469-477.
62. Kolbach DN, Sandbrink MW, Hamulyak K, Neumann HA, Prins MH. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev. 2004;1: CD004174.
63. Ageno W, Piantanida E, Dentali F, et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost. 2003;89:305-309.
64. van Ommen CH, Heijboer H, van den Dool EJ, et al. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost. 2003;1:2516-2522.
65. Mathew P, Manco-Johnson M, Hutter JJ, et al. Early clot recurrence or progression is not increased in children with genetic thrombophilia: preliminary results from the Regional Thrombophilia Registry Eight and Ten (the ReTREAT Study) [abstract]. Blood. 2003;102:548a. Abstract 2011.
66. Nuss R, Hays T, Manco-Johnson M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Amer J Pediatr Hematol/Oncol. 1994;16:127-131.
67. Shroff M, deVeber G. Sinovenous thrombosis in children. Neuroimaging Clin N Am. 2003;13:115-138.
68. Stam J, DeBrujin S, deVeber G. Anticoagulation for cerebral sinus thrombosis. Stroke. 2003;34:1054-1055.
69. Risch L, Fischer JE, Herklotz R, Huber AR. Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes. Intensive Care Med. 2004;30:1615-1624.
70. Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and a review of the literature. Thromb Haemost. 2004;91:719-724.
71. Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relations with source of medical care. Blood. 2000;96:437-442.